An inhibitor of the PD-1/PD-L1 protein-protein interaction
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

BMS-1001

Item No. 45922

Product Insert (PDF)
Technical Information
Formal Name
N-[[2-[(3-cyanophenyl)methoxy]-4-[[3-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-methylphenyl]methoxy]-5-methylphenyl]methyl]-D-serine
CAS Number
2113650-03-4
Molecular Formula
C35H34N2O7
Formula Weight
594.7
Purity
≥95%
Formulation (Request formulation change)
A solid
Solubility(Learn about Variance in Solubility)
DMSO: Sparingly soluble: 1-10 mg/ml
SMILES
CC1=C(COC2=CC(OCC3=CC=CC(C#N)=C3)=C(CN[C@@H](C(O)=O)CO)C=C2C)C=CC=C1C(C=C4)=CC5=C4OCCO5
InChi Code
InChI=1S/C35H34N2O7/c1-22-13-28(18-37-30(19-38)35(39)40)33(43-20-25-6-3-5-24(14-25)17-36)16-32(22)44-21-27-7-4-8-29(23(27)2)26-9-10-31-34(15-26)42-12-11-41-31/h3-10,13-16,30,37-38H,11-12,18-21H2,1-2H3,(H,39,40)/t30-/m1/s1
InChi Key
UWNXGZKSIKQKAH-SSEXGKCCSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    1 mg

    $89

    Add

    5 mg

    $267

    Add
    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    BMS-1001 is an inhibitor of the protein-protein interaction between programmed cell death protein 1 (PD-1) and PD-1 ligand (PD-L1; IC50 = 2.25 nM in a cell-free assay).1 It has been used in the synthesis of a proteolysis-targeting chimera (PROTAC) that drives PD-L1 degradation in MC-38 colon cancer cells.2 Conjugates containing BMS-1001 have been used as PET radiotracers for imaging PDL-1 expression in an A549-hPDL1 lung cancer mouse xenograft model.3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Guzik, K., Zak, K.M., Grudnik, P., et al. Small-molecule inhibitors of the programmed cell death-1/programmed death-ligand 1 (PD-1/PD-L1) interaction via transiently induced protein states and dimerization of PD-L1. J. Med. Chem. 60(13), 5857-5867 (2017).

    2. Qi, Q., Zhang, Z., Ji, X., et al. Rational design of PROTAC degraders and their spatiotemporal controlled delivery for enhanced tumor penetration and PD-L1 protein degradation. J. Med. Chem. 68(21), 22665-22688 (2025).

    3. Huang, Y., Li, C., Li, Z., et al. Development and preclinical evaluation of [68Ga]BMSH as a new potent positron emission tomography tracer for imaging programmed death-ligand 1 expression. Pharmaceuticals (Basel) 16(10), 1487 (2023).